Compare Amphastar Pharmaceuticals Inc (AMPH) vs Toyota Motor Corp (TM) Price & Performance

AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.

The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.

Toyota Motor (TM) trades at $176.45, up 1.22% today, with a neutral technical signal and strong fundamentals including a P/E of 9.67 and three consecutive quarterly EPS beats. The company announced a $3.6 billion Texas plant expansion to shift Tacoma production from Mexico, signaling strategic U.S. investment. Revenue grew to $48.04T in 2025, though net income dipped slightly to $4.77T, while cash flow trends show projected recovery in 2026.

TM presents a value opportunity with low valuation multiples and consistent profitability, but faces risks from competitive pressures and fluctuating margins. Analyst consensus is mixed with 37.5% buy ratings, reflecting cautious optimism amid hybrid vehicle strength and macroeconomic uncertainties. The stock's outlook hinges on execution of expansion plans and sustained demand for fuel-efficient models.